Burkitt lymphoma in the mouse. J Exp Med 2000 Oct 16;192(8):1183-90
Date
10/18/2000Pubmed ID
11034608Pubmed Central ID
PMC2195876DOI
10.1084/jem.192.8.1183Scopus ID
2-s2.0-0034675943 (requires institutional sign-in at Scopus site) 183 CitationsAbstract
Chromosomal translocations juxtaposing the MYC protooncogene with regulatory sequences of immunoglobulin (Ig) H chain or kappa (Ig kappa) or lambda (Ig lambda) L chain genes and effecting deregulated expression of MYC are the hallmarks of human Burkitt lymphoma (BL). Here we report that lymphomas with striking similarities to BL develop in mice bearing a mutated human MYC gene controlled by a reconstructed Ig lambda locus encompassing all the elements required for establishment of locus control in vitro. Diffusely infiltrating lymphomas with a typical starry sky appearance occurred in multiple founders and an established line, indicating independence from positional effects. Monoclonal IgM(+)CD5(-)CD23(-) tumors developed from an initially polyclonal population of B cells. These results demonstrate that the phenotype of B lineage lymphomas induced by MYC dysregulation is highly dependent on cooperativity among the regulatory elements that govern expression of the protooncogene and provide a new system for studying the pathogenesis of BL.
Author List
Kovalchuk AL, Qi CF, Torrey TA, Taddesse-Heath L, Feigenbaum L, Park SS, Gerbitz A, Klobeck G, Hoertnagel K, Polack A, Bornkamm GW, Janz S, Morse HC 3rdAuthor
Siegfried Janz MD Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AnimalsBurkitt Lymphoma
Disease Models, Animal
Exons
Genes, myc
Humans
Mice
Mice, Inbred C57BL
Mice, Transgenic
Proto-Oncogene Proteins c-myc
Spleen
